These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2526667)

  • 1. Decreased accessibility of platelet-bound fibrinogen to antibody and enzyme probes.
    Peerschke EI
    Blood; 1989 Aug; 74(2):682-9. PubMed ID: 2526667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of platelet-associated fibrinogen by polyclonal antibodies: correlation with platelet aggregation.
    Peerschke EI
    Blood; 1992 Apr; 79(8):2028-33. PubMed ID: 1562729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adhesive protein expression on thrombin-stimulated platelets: time-dependent modulation of anti-fibrinogen, -fibronectin, and -von Willebrand factor antibody binding.
    Peerschke EI
    Blood; 1992 Feb; 79(4):948-53. PubMed ID: 1737104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A murine monoclonal antibody that blocks fibrinogen binding to normal platelets also inhibits fibrinogen interactions with chymotrypsin-treated platelets.
    Peerschke EI; Coller BS
    Blood; 1984 Jul; 64(1):59-63. PubMed ID: 6733283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-fibrinogen antibody mediates fibrinogen binding to platelet membrane glycoprotein IIb-IIIa.
    Mohri H; Tanabe J; Fujita H; Kanamori H; Ohkubo T
    Br J Haematol; 1993 Oct; 85(2):341-7. PubMed ID: 8280606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fibrinogen receptor-mediated platelet aggregation by heterologous anti-human platelet membrane antibody. Significance of an Mr = 66,000 protein derived from glycoprotein IIIa.
    Kornecki E; Tuszynski GP; Niewiarowski S
    J Biol Chem; 1983 Aug; 258(15):9349-56. PubMed ID: 6308003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
    J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
    Pidard D; Frelinger AL; Bouillot C; Nurden AT
    Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent association between platelet-bound fibrinogen and the Triton X-100 insoluble cytoskeleton.
    Peerschke EI
    Blood; 1991 Feb; 77(3):508-14. PubMed ID: 1899346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet membrane alterations induced by the local anesthetic dibucaine.
    Peerschke EI
    Blood; 1986 Aug; 68(2):463-71. PubMed ID: 3015284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of 125I-labelled fibrin(ogen) fragments to platelets and to immunoprecipitated glycoprotein IIb-IIIa complex.
    Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
    Thromb Res; 1986 Jun; 42(5):645-59. PubMed ID: 2424122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
    Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogen.
    Gralnick HR; Williams SB; McKeown L; Shafer B; Connaghan GD; Hansmann K; Vail M; Magruder L
    Br J Haematol; 1992 Mar; 80(3):347-57. PubMed ID: 1374628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences.
    Pasche B; Ouimet H; Francis S; Loscalzo J
    Blood; 1994 Jan; 83(2):404-14. PubMed ID: 8286740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces.
    Shiba E; Lindon JN; Kushner L; Matsueda GR; Hawiger J; Kloczewiak M; Kudryk B; Salzman EW
    Am J Physiol; 1991 May; 260(5 Pt 1):C965-74. PubMed ID: 2035620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
    Shido K; Ahmad G; Hsu L; Kamiyama M
    J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
    Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
    Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.